porfiromycin

DRUG4 trials

Sponsors

Yale University, Boehringer Ingelheim

Conditions

Carcinoma of Unknown PrimaryHead and Neck CancerHead and Neck Neoplasms

Phase 1

Pharmacokinetic Study of Porfiromycin in Head and Neck Cancer and Other Cancer Patients With Solid Tumors

TerminatedNCT02209701

Boehringer IngelheimHead and Neck Neoplasms

Start: 1999-12-31Updated: 2014-08-06

Phase 3

Radiation Therapy Plus Porfiromycin in Treating Patients With Stage III or Stage IV Head and Neck Cancer

CompletedNCT00003328

Boehringer IngelheimHead and Neck Cancer

Start: 1997-12-31Target: 600Updated: 2010-05-21

Radiation Therapy and Chemotherapy in Treating Patients With Head and Neck Cancer

CompletedNCT00002507

Yale UniversityCarcinoma of Unknown Primary, Head and Neck Cancer

Start: 1992-11-30End: 2002-10-31Updated: 2013-07-25

Porfiromycin Used as an Adjuvant to Radiation Therapy in Postoperative Head and Neck Cancer Patients

TerminatedNCT02183246

Boehringer IngelheimHead and Neck Neoplasms

Start: 2000-05-31Updated: 2014-07-08